68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.

MLA

Fu, Hao, et al. “68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.” Clinical Nuclear Medicine, vol. 46, no. 11, Nov. 2021, pp. 940–42. EBSCOhost, https://doi.org/10.1097/RLU.0000000000003730.

APA

Fu, H., Fu, J., Huang, J., Pang, Y., & Chen, H. (2021). 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer. Clinical Nuclear Medicine, 46(11), 940–942. https://doi.org/10.1097/RLU.0000000000003730

Chicago

Fu, Hao, Jie Fu, Jingxiong Huang, Yizhen Pang, and Haojun Chen. 2021. “68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.” Clinical Nuclear Medicine 46 (11): 940–42. doi:10.1097/RLU.0000000000003730.